Trial ID or NCT#

NCT02160145

Status

NOT RECRUITING

Purpose

The purpose of the study is to determine whether tolvaptan is effective and safe for the treatment of late-stage chronic kidney disease due to autosomal dominant polycystic kidney disease (ADPKD).

Investigator(s)

Richard Lafayette, MD

Contact us to find out if this trial is right for you.

CONTACT

Kshama Mehta
(650) 736-1822